Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism

PHASE3CompletedINTERVENTIONAL
Enrollment

2,564

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

May 31, 2009

Conditions
Thromboembolism
Interventions
DRUG

dabigatran etexilate 150 mg

twice daily

DRUG

warfarin (INR 2-3)

prn to maintain INR (2-3)

Trial Locations (250)

Unknown

1160.53.01035 Boehringer Ingelheim Investigational Site, Mobile

1160.53.01056 Boehringer Ingelheim Investigational Site, Hartford

1160.53.01044 Boehringer Ingelheim Investigational Site, Clearwater

1160.53.01033 Boehringer Ingelheim Investigational Site, Sarasota

1160.53.01046 Boehringer Ingelheim Investigational Site, Sarasota

1160.53.01019 Boehringer Ingelheim Investigational Site, Augusta

1160.53.01008 Boehringer Ingelheim Investigational Site, Decatur

1160.53.01010 Boehringer Ingelheim Investigational Site, Marietta

1160.53.01014 Boehringer Ingelheim Investigational Site, Baltimore

1160.53.01023 Boehringer Ingelheim Investigational Site, Detroit

1160.53.01029 Boehringer Ingelheim Investigational Site, Pontiac

1160.53.01009 Boehringer Ingelheim Investigational Site, Saint Louis Park

1160.53.01031 Boehringer Ingelheim Investigational Site, Lebanon

1160.53.01036 Boehringer Ingelheim Investigational Site, Albuquerque

1160.53.01025 Boehringer Ingelheim Investigational Site, Valhalla

1160.53.01027 Boehringer Ingelheim Investigational Site, Chapel Hill

1160.53.01039 Boehringer Ingelheim Investigational Site, Winston-Salem

1160.53.01030 Boehringer Ingelheim Investigational Site, Grand Forks

1160.53.01013 Boehringer Ingelheim Investigational Site, Toledo

1160.53.01028 Boehringer Ingelheim Investigational Site, Portland

1160.53.01052 Boehringer Ingelheim Investigational Site, Altoona

1160.53.01055 Boehringer Ingelheim Investigational Site, Summerville

1160.53.01017 Boehringer Ingelheim Investigational Site, Richmond

1160.53.54017 Boehringer Ingelheim Investigational Site, Adrogué

1160.53.54003 Boehringer Ingelheim Investigational Site, Capital Federal

1160.53.54005 Boehringer Ingelheim Investigational Site, Capital Federal

1160.53.54006 Boehringer Ingelheim Investigational Site, Capital Federal

1160.53.54007 Boehringer Ingelheim Investigational Site, Capital Federal

1160.53.54010 Boehringer Ingelheim Investigational Site, Capital Federal

1160.53.61002 Boehringer Ingelheim Investigational Site, Woolloongabba

1160.53.61004 Boehringer Ingelheim Investigational Site, Bedford Park

1160.53.61003 Boehringer Ingelheim Investigational Site, Box Hill

1160.53.61001 Boehringer Ingelheim Investigational Site, Clayton

1160.53.61006 The Avenue Cardiovascular Centre, Windsor

1160.53.61005 Boehringer Ingelheim Investigational Site, Perth

1160.53.43001 Boehringer Ingelheim Investigational Site, Graz

1160.53.43003 Boehringer Ingelheim Investigational Site, Innsbruck

1160.53.43002 Boehringer Ingelheim Investigational Site, Vienna

1160.53.32001 Boehringer Ingelheim Investigational Site, Brussels

1160.53.32002 Boehringer Ingelheim Investigational Site, Brussels

1160.53.32003 Boehringer Ingelheim Investigational Site, Brussels

1160.53.32007 Boehringer Ingelheim Investigational Site, Edegem

1160.53.32005 Boehringer Ingelheim Investigational Site, Leuven

1160.53.32004 Boehringer Ingelheim Investigational Site, Liège

1160.53.55010 Boehringer Ingelheim Investigational Site, Brasília

1160.53.55007 Boehringer Ingelheim Investigational Site, Campinas

1160.53.55001 Boehringer Ingelheim Investigational Site, Cerqueira César - Sao Paulo

1160.53.55002 Boehringer Ingelheim Investigational Site, Cerqueira César - São Paulo

1160.53.55014 Boehringer Ingelheim Investigational Site, Cristo Rei - Curitiba

1160.53.55011 Boehringer Ingelheim Investigational Site, Goiânia

1160.53.55017 Boehringer Ingelheim Investigational Site, Paraná

1160.53.55012 Boehringer Ingelheim Investigational Site, Porto Alegre

1160.53.55016 Boehringer Ingelheim Investigational Site, Rio de Janeiro - RJ

1160.53.55004 Boehringer Ingelheim Investigational Site, Santo André

1160.53.55005 Boehringer Ingelheim Investigational Site, São José do Rio Preto

1160.53.02006 Boehringer Ingelheim Investigational Site, Edmonton

1160.53.02013 Boehringer Ingelheim Investigational Site, Edmonton

1160.53.02021 Boehringer Ingelheim Investigational Site, Victoria

1160.53.02004 Boehringer Ingelheim Investigational Site, Saint Johns

1160.53.02001 Boehringer Ingelheim Investigational Site, Halifax

1160.53.02002 Boehringer Ingelheim Investigational Site, Hamilton

1160.53.02005 Boehringer Ingelheim Investigational Site, Hamilton

1160.53.02010 Boehringer Ingelheim Investigational Site, Hamilton

1160.53.02022 Boehringer Ingelheim Investigational Site, Hamilton

1160.53.02011 Boehringer Ingelheim Investigational Site, London

1160.53.02015 Boehringer Ingelheim Investigational Site, Ottawa

1160.53.02019 Boehringer Ingelheim Investigational Site, Toronto

1160.53.02008 Boehringer Ingelheim Investigational Site, Montreal

1160.53.02009 Boehringer Ingelheim Investigational Site, Montreal

1160.53.02014 Boehringer Ingelheim Investigational Site, Montreal

1160.53.02017 Boehringer Ingelheim Investigational Site, Montreal

1160.53.02020 Boehringer Ingelheim Investigational Site, Québec

1160.53.02003 Boehringer Ingelheim Investigational Site, Sainte-Foy

1160.53.42001 Boehringer Ingelheim Investigational Site, Brno

1160.53.42002 Boehringer Ingelheim Investigational Site, Hradec Králové

1160.53.42011 Boehringer Ingelheim Investigational Site, Hranice

1160.53.42009 Boehringer Ingelheim Investigational Site, Jihlava

1160.53.42012 Boehringer Ingelheim Investigational Site, Liberec

1160.53.42015 Boehringer Ingelheim Investigational Site, Nový Jičín

1160.53.42005 Boehringer Ingelheim Investigational Site, Ostrava-Vitkovice

1160.53.42004 Boehringer Ingelheim Investigational Site, Prague

1160.53.42014 Boehringer Ingelheim Investigational Site, Tábor

1160.53.42016 Boehringer Ingelheim Investigational Site, Teplice

1160.53.42010 Boehringer Ingelheim Investigational Site, Ústí nad Labem

1160.53.42007 Boehringer Ingelheim Investigational Site, Zlín

1160.53.45008 Boehringer Ingelheim Investigational Site, Esbjerg

1160.53.45009 Boehringer Ingelheim Investigational Site, Holbæk

1160.53.45002 Boehringer Ingelheim Investigational Site, Kolding

1160.53.45004 Boehringer Ingelheim Investigational Site, København NV

1160.53.45007 Boehringer Ingelheim Investigational Site, København S

1160.53.45006 Boehringer Ingelheim Investigational Site, Slagelse

1160.53.3301A Boehringer Ingelheim Investigational Site, Brest

1160.53.3301B Boehringer Ingelheim Investigational Site, Brest

1160.53.3301C Boehringer Ingelheim Investigational Site, Brest

1160.53.3301D Boehringer Ingelheim Investigational Site, Brest

1160.53.3301E Boehringer Ingelheim Investigational Site, Brest

1160.53.3301F Boehringer Ingelheim Investigational Site, Brest

1160.53.3301H Boehringer Ingelheim Investigational Site, Brest

1160.53.3301I Boehringer Ingelheim Investigational Site, Brest

1160.53.3302A Boehringer Ingelheim Investigational Site, Lorient

1160.53.3310A Boehringer Ingelheim Investigational Site, Montpellier

1160.53.3310B Boehringer Ingelheim Investigational Site, Montpellier

1160.53.3310C Boehringer Ingelheim Investigational Site, Montpellier

1160.53.3308B Boehringer Ingelheim Investigational Site, Nancy

1160.53.3303B Boehringer Ingelheim Investigational Site, Saint-Etienne

1160.53.3303C Boehringer Ingelheim Investigational Site, Saint-Etienne

1160.53.3303D Boehringer Ingelheim Investigational Site, Saint-Etienne

1160.53.3303E Boehringer Ingelheim Investigational Site, Saint-Etienne

1160.53.3303A Boehringer Ingelheim Investigational Site, Saint-Priest-en-Jarez

1160.53.3311A Boehringer Ingelheim Investigational Site, Toulon Naval

1160.53.3311B Boehringer Ingelheim Investigational Site, Toulon Naval

1160.53.3311C Boehringer Ingelheim Investigational Site, Toulon Naval

1160.53.3311D Boehringer Ingelheim Investigational Site, Toulon Naval

1160.53.3311E Boehringer Ingelheim Investigational Site, Toulon Naval

1160.53.3308A Boehringer Ingelheim Investigational Site, Vandœuvre-lès-Nancy

1160.53.49003 Boehringer Ingelheim Investigational Site, Cologne

1160.53.49017 Boehringer Ingelheim Investigational Site, Dresden

1160.53.49018 Boehringer Ingelheim Investigational Site, Dresden

1160.53.49005 Boehringer Ingelheim Investigational Site, Mannheim

1160.53.49007 Boehringer Ingelheim Investigational Site, München

1160.53.49009 Boehringer Ingelheim Investigational Site, Püttlingen

1160.53.30001 Boehringer Ingelheim Investigational Site, Athens

1160.53.30005 Boehringer Ingelheim Investigational Site, Athens

1160.53.30006 Boehringer Ingelheim Investigational Site, Athens

1160.53.36001 Boehringer Ingelheim Investigational Site, Budapest

1160.53.36006 Boehringer Ingelheim Investigational Site, Budapest

1160.53.36002 Boehringer Ingelheim Investigational Site, Debrecen

1160.53.36013 Boehringer Ingelheim Investigational Site, Eger

1160.53.36012 Boehringer Ingelheim Investigational Site, Gyula

1160.53.36004 Boehringer Ingelheim Investigational Site, Miskolc

1160.53.36003 Boehringer Ingelheim Investigational Site, Pécs

1160.53.36010 Boehringer Ingelheim Investigational Site, Székesfehérvár

1160.53.36011 Boehringer Ingelheim Investigational Site, Szombathely

1160.53.91011 Boehringer Ingelheim Investigational Site, Bangalore

1160.53.91012 Boehringer Ingelheim Investigational Site, Chennai

1160.53.91019 Boehringer Ingelheim Investigational Site, Chennai

1160.53.91013 Boehringer Ingelheim Investigational Site, Indore

1160.53.91021 Boehringer Ingelheim Investigational Site, Karna

1160.53.91022 Boehringer Ingelheim Investigational Site, Kerala

1160.53.91020 Boehringer Ingelheim Investigational Site, Ludhiana

1160.53.91007 Boehringer Ingelheim Investigational Site, Mysore

1160.53.91015 Boehringer Ingelheim Investigational Site, Nagpur

1160.53.91010 Boehringer Ingelheim Investigational Site, New Delhi

1160.53.91005 Boehringer Ingelheim Investigational Site, Pune

1160.53.91008 Boehringer Ingelheim Investigational Site, Pune

1160.53.91004 Boehringer Ingelheim Investigational Site, Vadodara

1160.53.97202 Boehringer Ingelheim Investigational Site, Afula

1160.53.97207 Boehringer Ingelheim Investigational Site, Ashkelon

1160.53.97211 Boehringer Ingelheim Investigational Site, Haifa

1160.53.97203 Boehringer Ingelheim Investigational Site, Holon

1160.53.97205 Boehringer Ingelheim Investigational Site, KfarSaba

1160.53.97206 Boehringer Ingelheim Investigational Site, Petah Tikva

1160.53.97210 Boehringer Ingelheim Investigational Site, Tel Aviv

1160.53.97204 Boehringer Ingelheim Investigational Site, Tel Litwinsky

1160.53.97201 Boehringer Ingelheim Investigational Site, Ẕerifin

1160.53.39003 Boehringer Ingelheim Investigational Site, Bologna

1160.53.39002 Boehringer Ingelheim Investigational Site, Padua

1160.53.39001 Boehringer Ingelheim Investigational Site, Perugia

1160.53.39004 Boehringer Ingelheim Investigational Site, Reggio Emilia

1160.53.39007 Boehringer Ingelheim Investigational Site, Vimercate

1160.53.39005 Boehringer Ingelheim Investigational Site, Vittorio Veneto (tv)

1160.53.5264 Boehringer Ingelheim Investigational Site, Chihuahua City

1160.53.5270 Boehringer Ingelheim Investigational Site, Culiacán

1160.53.5262 Boehringer Ingelheim Investigational Site, San Luis Potosí City

1160.53.31010 Boehringer Ingelheim Investigational Site, 's-Hertogenbosch

1160.53.31001 Boehringer Ingelheim Investigational Site, Amersfoort

1160.53.31006 Boehringer Ingelheim Investigational Site, Amsterdam

1160.53.31013 Boehringer Ingelheim Investigational Site, Eindhoven

1160.53.31005 Boehringer Ingelheim Investigational Site, Maastricht

1160.53.31002 Boehringer Ingelheim Investigational Site, Nieuwegein

1160.53.31004 Boehringer Ingelheim Investigational Site, Rotterdam

1160.53.31009 Boehringer Ingelheim Investigational Site, Rotterdam

1160.53.64003 Boehringer Ingelheim Investigational Site, Auckland

1160.53.64004 Boehringer Ingelheim Investigational Site, Christchurch

1160.53.64002 Boehringer Ingelheim Investigational Site, Otahuhu Auckland

1160.53.64001 Boehringer Ingelheim Investigational Site, Takapuna Auckland

1160.53.47001 Boehringer Ingelheim Investigational Site, Oslo

1160.53.47004 Boehringer Ingelheim Investigational Site, Oslo

1160.53.47003 Boehringer Ingelheim Investigational Site, Rud

1160.53.47005 Boehringer Ingelheim Investigational Site, Trondheim

1160.53.35104 Boehringer Ingelheim Investigational Site, Almada

1160.53.35109 Boehringer Ingelheim Investigational Site, Coimbra

1160.53.35101 Boehringer Ingelheim Investigational Site, Lisbon

1160.53.35102 Boehringer Ingelheim Investigational Site, Lisbon

1160.53.35105 Boehringer Ingelheim Investigational Site, Lisbon

1160.53.07011 Boehringer Ingelheim Investigational Site, Chelyabinsk

1160.53.07021 Boehringer Ingelheim Investigational Site, Chelyabinsk

1160.53.07016 Boehringer Ingelheim Investigational Site, Krasnodar

1160.53.07004 Boehringer Ingelheim Investigational Site, Kursk

1160.53.07003 Boehringer Ingelheim Investigational Site, Moscow

1160.53.07010 Boehringer Ingelheim Investigational Site, Novosibirsk

1160.53.07020 Boehringer Ingelheim Investigational Site, Omsk

1160.53.07018 Boehringer Ingelheim Investigational Site, Pskov

1160.53.07009 Boehringer Ingelheim Investigational Site, Rostov-on-Don

1160.53.07023 Boehringer Ingelheim Investigational Site, Rostov-on-Don

1160.53.07024 Boehringer Ingelheim Investigational Site, Rostov-on-Don

1160.53.07025 Boehringer Ingelheim Investigational Site, Rostov-on-Don

1160.53.07001 Boehringer Ingelheim Investigational Site, Saint Petersburg

1160.53.07014 Boehringer Ingelheim Investigational Site, Ufa

1160.53.07005 Boehringer Ingelheim Investigational Site, Yaroslavl

1160.53.07006 Boehringer Ingelheim Investigational Site, Yaroslavl

1160.53.07007 Boehringer Ingelheim Investigational Site, Yekaterinburg

1160.53.42107 Boehringer Ingelheim Investigational Site, Banská Bystrica

1160.53.42106 Boehringer Ingelheim Investigational Site, Lučenec

1160.53.42102 Boehringer Ingelheim Investigational Site, Nitra

1160.53.42103 Boehringer Ingelheim Investigational Site, Nové Zámky

1160.53.42104 Boehringer Ingelheim Investigational Site, Žilina

1160.53.27007 Boehringer Ingelheim Investigational Site, Centurion

1160.53.27001 Boehringer Ingelheim Investigational Site, Johannesburg

1160.53.27002 Boehringer Ingelheim Investigational Site, Johannesburg

1160.53.27004 Boehringer Ingelheim Investigational Site, Johannesburg

1160.53.27006 Boehringer Ingelheim Investigational Site, Johannesburg

1160.53.27009 Suite 404, Medical Centre, Pretoria

1160.53.27003 Boehringer Ingelheim Investigational Site, Randburg

1160.53.27008 Suite M5, Second Floor, Richards Bay

1160.53.27005 Boehringer Ingelheim Investigational Site, Roodepoort

1160.53.34012 Boehringer Ingelheim Investigational Site, Badalona (Barcelona)

1160.53.34001 Boehringer Ingelheim Investigational Site, Barcelona

1160.53.34002 Boehringer Ingelheim Investigational Site, Barcelona

1160.53.34007 Boehringer Ingelheim Investigational Site, Cartagena. Murcia

1160.53.34003 Boehringer Ingelheim Investigational Site, Cuenca

1160.53.34009 Boehringer Ingelheim Investigational Site, Madrid

1160.53.34010 Boehringer Ingelheim Investigational Site, Madrid

1160.53.34004 Boehringer Ingelheim Investigational Site, Santander

1160.53.34005 Boehringer Ingelheim Investigational Site, Torrelavega.Santander

1160.53.34011 Boehringer Ingelheim Investigational Site, Valencia

1160.53.46002 Boehringer Ingelheim Investigational Site, Gothenburg

1160.53.46006 Boehringer Ingelheim Investigational Site, Jönköping

1160.53.46001 Boehringer Ingelheim Investigational Site, Stockholm

1160.53.46007 Boehringer Ingelheim Investigational Site, Stockholm

1160.53.46008 Boehringer Ingelheim Investigational Site, Stockholm

1160.53.46005 Boehringer Ingelheim Investigational Site, Sundsvall

1160.53.46003 Boehringer Ingelheim Investigational Site, Uppsala

1160.53.90003 Boehringer Ingelheim Investigational Site, Ankara

1160.53.90004 Boehringer Ingelheim Investigational Site, Ankara

1160.53.90005 Boehringer Ingelheim Investigational Site, Ankara

1160.53.90001 Boehringer Ingelheim Investigational Site, Istanbul

1160.53.90002 Boehringer Ingelheim Investigational Site, Istanbul

1160.53.90007 Boehringer Ingelheim Investigational Site, Istanbul

1160.53.90006 Boehringer Ingelheim Investigational Site, Izmir

1160.53.38006 Boehringer Ingelheim Investigational Site, Kiev

1160.53.38005 Boehringer Ingelheim Investigational Site, Vinnitsa

1160.53.38003 Boehringer Ingelheim Investigational Site, Zaporizhzhya

1160.53.44008 Boehringer Ingelheim Investigational Site, Aberdeen

1160.53.44005 Boehringer Ingelheim Investigational Site, Headington, Oxford

1160.53.44004 Boehringer Ingelheim Investigational Site, London

1160.53.44009 Boehringer Ingelheim Investigational Site, London

1160.53.44011 Boehringer Ingelheim Investigational Site, London

1160.53.44006 Boehringer Ingelheim Investigational Site, Newcastle upon Tyne

1160.53.44012 Boehringer Ingelheim Investigational Site, Sheffield

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00291330 - Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism | Biotech Hunter | Biotech Hunter